Chemistry Reference
In-Depth Information
[75] Geschwindner, S., Olsson, L. L., Albert, J. S., Deinum, J., Edwards, P. D., de Beer, T.,
and Folmer, R. H. A. (2007). Discovery of a novel warhead against beta-secretase through
fragment-based lead generation.
Journal of Medicinal Chemistry
50
, 5903-5911.
[76] Williams, B. (2007). Fragment based drug discovery - from crystal to clinic.
Journal of
Pharmacy and Pharmacology
59
, A77.
[77] Kuglstatter, A., Stahl, M., Peters, J.-U., Huber, W., Stihle, M., Schlatter, D., Benz, J., Ruf,
A., Roth, D., Enderle, T., and Hennig, M. (2008). Tyramine fragment binding to BACE-1.
Bioorganic and Medicinal Chemistry Letters
18
, 1304-1307.
[78] Talhout, R., Villa, A., Mark, A. E., and Engberts, J. B. F. N. (2003). Understanding binding
affinity: a combined isothermal titration calorimetry/molecular dynamics study of the binding
of a series of hydrophobically modified benzamidinium chloride inhibitors to trypsin.
Journal
of the American Chemical Society
125
, 10570-10579.
[79] Turnbull, W. B., and Daranas, A. H. (2003). On the value of
c
: can low affinity systems by
studied by isothermal titration calorimetry.
Journal of the American Chemical Society
125
,
14859-14866.
[80] Trosset, J. Y., Dalvit, C., Knapp, S., Fasolini, M., Veronesi, M., Mantegani, S., Gianellini,
L. M., Catana, C., Sundstrom, M., Stouten, P. F. W., and Moll, J. K. (2006). Inhibition of
protein-protein interactions: the discovery of druglike beta-catenin inhibitors by combin-
ing virtual and biophysical screening.
Proteins: Structure
,
Function and Bioinformatics
64
, 60-67.
[81] Inglese, J., Johnson, R. L., Simeonov, A., Xia, M. H., Zheng, W., Austin, C. P., and Auld, D.
S. (2007). High-throughput screening assays for the identification of chemical probes.
Nature
Chemical Biology
3
, 466-479.
[82] Pereira, D. A., and Williams, J. A. (2007). Origin and evolution of high throughput screening.
British Journal of Pharmacology
152
, 53-61.
[83] Cummings, M. D., Farnum, M. A., and Nelen, M. I. (2006). Universal screening methods and
applications of ThermoFluor(R).
Journal of Biomolecular Screening
11
, 854-863.
[84] Koblish, H. K., Zhao, S., Franks, C. F., Donatelli, R. R., Tominovich, R. M., LaFrance, L. V.,
Leonard, K. A., Gushue, J. M., Parks, D. J., Calvo, R. R., Milkiewicz, K. L., Marugan, J. J.,
Raboisson, P., Cummings, M. D., Grasberger, B. L., Johnson, D. L., Lu, T., Molloy, C. J., and
Maroney, A. C. (2006). Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress
human tumor cell proliferation
in vitro
and sensitize tumors to doxorubicin
in vivo
.
Molecular
Cancer Therapeutics
5
, 160-169.
[85] Homans, S. W. (2005). Probing the binding entropy of ligand-protein interactions by NMR.
ChemBioChem
6
, 1585-1591.
[86] Perozzo, R., Folkers, G., and Scapozza, L. (2004). Thermodynamics of protein-ligand inter-
actions: history, presence and future aspects.
Journal of Receptor and Signal Transduction
Research
24
, 1-52.
[87] Alex, A. A., and Flocco, M. M. (2007). Fragment-based drug discovery: what has it achieved
so far?
Current Topics in Medicinal Chemistry
7
, 1544-1567.
[88] Milligan, G., and Smith, N. J. (2007). Allosteric modulation of heterodimeric
G-protein-coupled receptors.
Trends in Pharmacological Sciences
28
, 615-620.
[89] Beher, D. (2008). Gamma-secretase modulation and its promise for Alzheimer's disease: a
rationale for drug discovery.
Current Topics in Medicinal Chemistry
8
, 34-37.
[90] Wong, C.-H., Hendrix, M., Manning, D. D., Rosenbohm, C., and Greenberg, W. A. (1998).
A library approach to the discovery of small molecules that recognize RNA: use of a
1,3-hydroxyamine motif as core.
Journal of the American Chemical Society
120
, 8319-8327.
[91] Lepre, C. A. (2001). Library design for NMR-based screening.
Drug Discovery Today
6
,
133-140.
